Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blinded, Parallel Group Study to Demonstrate the Adherence and Efficacy of Different Doses of Iron Supplement in Subjects With or At-risk of Iron Deficiency With a History of Intolerance to Oral Iron

NCT04778072 is registered in ClinicalTrials.gov with Solvotrin Innovations Ltd as lead sponsor.

NCT NCT04778072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04778072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blinded, Parallel Group Study to Demonstrate the Adherence and Efficacy of Different Doses of Iron Supplement in Subjects With or At-risk of Iron Deficiency With a History of Intolerance to Oral Iron
Lead sponsor
Solvotrin Innovations Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
October 8, 2018
Completion date
May 15, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heavy menstrual bleeding, iron adverse reaction, iron deficiency anemia, iron-deficiency, premenopause